id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2019-D-1828-0009,FDA,FDA-2019-D-1828,E19 A SELECTIVE APPROACH TO SAFETY DATA COLLECTION IN SPECIFIC LATE-STAGE PREAPPROVAL OR POST-APPROVAL CLINICAL TRIALS,Other,Guidance,2022-12-06T05:00:00Z,2022,12,2022-12-06T05:00:00Z,,2025-07-24T09:00:23Z,,1,0,090000648551c1c7
FDA-2019-D-1828-0008,FDA,FDA-2019-D-1828,E19 A Selective Approach to Safety Data Collection in Specific Late-Stage Pre-Approval or Post-Approval Clinical Trials; International Council for Harmonisation; Guidance for Industry; Availability,Notice,Notice of Availability,2022-12-06T05:00:00Z,2022,12,2022-12-06T05:00:00Z,,2022-12-06T13:19:55Z,2022-26433,0,0,090000648551e24f
FDA-2019-D-1828-0001,FDA,FDA-2019-D-1828,"E19 Optimisation of Safety Data Collection; International Council for
Harmonisation; Draft Guidance for Industry; Availability",Notice,Notice of Availability,2019-06-27T04:00:00Z,2019,6,2019-06-27T04:00:00Z,2019-09-26T03:59:59Z,2019-09-26T01:05:09Z,2019-13702,0,0,0900006483d46dc0
FDA-2019-D-1828-0002,FDA,FDA-2019-D-1828,Draft Guidance for Industry E19 Optimisation of Safety Data Collection,Other,,2019-06-27T00:00:00Z,2019,6,,,2024-11-12T23:02:41Z,,0,1,0900006483d474c1
FDA-2019-D-1828-0003,FDA,FDA-2019-D-1828,International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use; ICH Harmonised Guidelin; E19 Optimisation of Safety Data Collection,Other,Guidance,2019-06-26T04:00:00Z,2019,6,2019-06-26T04:00:00Z,,2022-12-06T13:33:09Z,,0,0,0900006483db1bd3